Back

Atrial fibrillation progression and circulating biomarkers: insights from the RACE V study

12 April 2026 (08:00 - 15:30)
Organised by: Logo
Congress Presentation Part of: Clinical aspects of atrial fibrillation management Clinical EHRA Premium Access EHRA 2026 European Heart Rhythm Association (EHRA)

About the speaker

Photo
Mr Dawid K Baron

Groningen (Netherlands (The))

5 More presentations in this session

Presentation thumbnail
Improving risk factor management in atrial fibrillation: a quality improvement project at a district general hospital
Doctor M. Elhadi (Blackburn, GB)
Abstract Slides Video
Presentation thumbnail
Epicardial and pericardial adipose tissue and circulating biomarkers in patients with atrial fibrillation: insights from the RACE V study
Doctor M. Lobeek (Groningen, NL)
Abstract Slides Video
Presentation thumbnail
Impact of a standardised same-day discharge checklist on length of stay after pulsed-field atrial fibrillation ablation
Doctor I. antoun (Leicester, GB)
Abstract Slides Video
Presentation thumbnail
The effect of transcatheter aortic valve implantation on preexisting atrial tachyarrhythmias
Doctor Z. Dadon (Jerusalem, IL)
Abstract Slides Video
Presentation thumbnail
Association between oxidative balance status and left atrial substrate assessed by 3D ultra-high-density mapping
Doctor R. Albarran-Rincon (Pamplona, ES)
Abstract Slides Video

Access the full session

Session thumbnail
Clinical aspects of atrial fibrillation management

The Event

Event poster

EHRA 2026

12 April - 14 April 2026
You may be interested in
thumbnail
Congress Presentation
Atrial fibrillation progression and healthcare burden: data from the RACE V study
thumbnail
Congress Presentation
Biomarkers in atrial fibrillation: insights from the ACaSA study
thumbnail
Congress Presentation
Comprehensive assessment of novel biomarkers in atrial fibrillation

ESC 365 is supported by

novartis Explore sponsored resources

ESC 365 is supported by

novartis Explore sponsored resources